The Accelerator will identify microbiome research with the potential to transform human health outcomes. Four carefully chosen applicants will be awarded $10,000 and gain entry to our immersive residential program that provides the training, mentorship and connections to translate groundbreaking research for maximum impact. The deadline for applications is 24 June 2024.

On the second episode of our new podcast series, Associate Editor Cláudia Vilhena talks with co-authors Siyu He, Yinuo Jin and Lingting Shi about Starfysh, a computational toolbox combining spatial transcriptomics and histology data. They dig into the layers of Starfysh and its relevance for cancer research, and share the struggles of peer review and the wonders of collaborative work.

Our March issue covers active biopharma companies and landscape feature articles covering both the fields of oncology and molecular diagnostics.

The commercial success of second-generation radiopharmaceuticals in oncology has re-ignited interest in this modality, resulting in a surge of dealmaking and increased venture financing for companies in the field.